130 related articles for article (PubMed ID: 6390841)
1. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
[No Abstract] [Full Text] [Related]
2. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
[No Abstract] [Full Text] [Related]
3. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
[TBL] [Abstract][Full Text] [Related]
4. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
[TBL] [Abstract][Full Text] [Related]
5. Class II antigens and interleukin 2 expression in renal allograft recipients.
Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A
Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133
[No Abstract] [Full Text] [Related]
6. Cytotoxic antibodies to B lymphocytes in kidney transplant patients.
Luciani G; Castagneto M; Monari C; Renna E
Transplant Proc; 1979 Jun; 11(2):1265-6. PubMed ID: 382503
[No Abstract] [Full Text] [Related]
7. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
[No Abstract] [Full Text] [Related]
9. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
Lordon RE; Wilson RL; Shield CF; Ferrone S
Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
[TBL] [Abstract][Full Text] [Related]
10. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
Moen T; Berger L; Goyer K; Dahl O; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
[No Abstract] [Full Text] [Related]
11. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
Creemers P; Brink J; Kahn D
Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
[TBL] [Abstract][Full Text] [Related]
12. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
[No Abstract] [Full Text] [Related]
13. Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients.
Deierhoi MH; Radvany RM; Wolf JS
Transplant Proc; 1981 Mar; 13(1 Pt 2):942-4. PubMed ID: 7022966
[No Abstract] [Full Text] [Related]
14. Enhanced kidney allograft survival across a positive crossmatch (Cx) arising from B-cell specific and cold reactive antibodies (Ab).
Lobo P; Rudolf L; Westervelt FB
Proc Clin Dial Transplant Forum; 1977; 7():4-6. PubMed ID: 356038
[No Abstract] [Full Text] [Related]
15. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
[TBL] [Abstract][Full Text] [Related]
16. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
17. The influence of HLA-DR match on cadaveric renal graft survival. Experience from Stockholm.
Berg B; Groth CG; Gunnarsson R; Lundgren G; Möller E; Ringdén O
Scand J Urol Nephrol Suppl; 1981; 64():38-45. PubMed ID: 6815793
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
[No Abstract] [Full Text] [Related]
19. HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation.
Albrechtsen D; Flatmark A; Halvorsen S; Jervell J; Solheim BG; Thorsby E
Scand J Urol Nephrol Suppl; 1980; 54():25-8. PubMed ID: 7013036
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR matching and B-cell crossmatching in renal transplantation.
Ting A; Williams KA; Morris PJ
Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
